Anderson FH - Search Results

1

Sustained responders have better quality of life and productivity compared with treatment failures long after antiviral therapy for hepatitis C.

John-Baptiste AA, Tomlinson G, Hsu PC, Krajden M, Heathcote EJ, Laporte A, Yoshida EM, Anderson FH, Krahn MD. John-Baptiste AA, et al. Among authors: anderson fh. Am J Gastroenterol. 2009 Oct;104(10):2439-48. doi: 10.1038/ajg.2009.346. Epub 2009 Jun 30. Am J Gastroenterol. 2009. PMID: 19568230

2

Health utilities and psychometric quality of life in patients with early- and late-stage hepatitis C virus infection.

Hsu PC, Federico CA, Krajden M, Yoshida EM, Bremner KE, Anderson FH, Weiss AA, Krahn MD. Hsu PC, et al. Among authors: anderson fh. J Gastroenterol Hepatol. 2012 Jan;27(1):149-57. doi: 10.1111/j.1440-1746.2011.06813.x. J Gastroenterol Hepatol. 2012. PMID: 21679248

3

Does cirrhosis affect quality of life in hepatitis C virus-infected patients?

Hsu PC, Krajden M, Yoshida EM, Anderson FH, Tomlinson GA, Krahn MD. Hsu PC, et al. Among authors: anderson fh. Liver Int. 2009 Mar;29(3):449-58. doi: 10.1111/j.1478-3231.2008.01865.x. Liver Int. 2009. PMID: 19267865

4

Patient time costs and out-of-pocket costs in hepatitis C.

Federico CA, Hsu PC, Krajden M, Yoshida EM, Bremner KE, Weiss AA, Anderson FH, Krahn MD. Federico CA, et al. Among authors: anderson fh. Liver Int. 2012 May;32(5):815-25. doi: 10.1111/j.1478-3231.2011.02722.x. Epub 2012 Jan 3. Liver Int. 2012. PMID: 22221745

5

Outcomes of peginterferon alpha-2a and ribavirin hepatitis C therapy in Aboriginal Canadians.

Cooper CL, Bailey RJ, Bain VG, Anderson F, Yoshida EM, Krajden M, Marotta P; Canadian Pegasys Study Group. Cooper CL, et al. Can J Gastroenterol. 2008 Aug;22(8):677-80. doi: 10.1155/2008/320150. Can J Gastroenterol. 2008. PMID: 18701944 Free PMC article.

6

Failure of ketoprofen and interferon combination therapy to improve interferon-resistant chronic hepatitis C.

Anderson FH, Zeng L, Yoshida EM, Rock NR. Anderson FH, et al. Can J Gastroenterol. 1997 May-Jun;11(4):294-7. doi: 10.1155/1997/562402. Can J Gastroenterol. 1997. PMID: 9218853

7

Peginterferon alfa-2a (40KD) plus ribavirin in chronic hepatitis C patients who failed previous interferon therapy.

Sherman M, Yoshida EM, Deschenes M, Krajden M, Bain VG, Peltekian K, Anderson F, Kaita K, Simonyi S, Balshaw R, Lee SS; Canadian Pegasys Study Group. Sherman M, et al. Gut. 2006 Nov;55(11):1631-8. doi: 10.1136/gut.2005.083113. Epub 2006 May 18. Gut. 2006. PMID: 16709661 Free PMC article. Clinical Trial.

8

Transcription-mediated amplification is more sensitive than conventional PCR-based assays for detecting residual serum HCV RNA at end of treatment.

Comanor L, Anderson F, Ghany M, Perrillo R, Heathcote EJ, Sherlock C, Zitron I, Hendricks D, Gordon SC. Comanor L, et al. Am J Gastroenterol. 2001 Oct;96(10):2968-72. doi: 10.1111/j.1572-0241.2001.04669.x. Am J Gastroenterol. 2001. PMID: 11693334

9

The use of interferon-alpha 2B in the treatment of chronic viral hepatitis in patients with preexisting idiopathic thrombocytopenic purpura.

Yoshida EM, Rock NR, Zeng L, Haniak WA, Anderson FH. Yoshida EM, et al. Among authors: anderson fh. Am J Gastroenterol. 1995 May;90(5):854-5. Am J Gastroenterol. 1995. PMID: 7605454 No abstract available.

10

Alteration of the dismal natural history of fibrosing cholestatic hepatitis secondary to hepatitis B virus with the use of lamivudine.

Al Faraidy K, Yoshida EM, Davis JE, Vartanian RK, Anderson FH, Steinbrecher UP. Al Faraidy K, et al. Among authors: anderson fh. Transplantation. 1997 Sep 27;64(6):926-8. doi: 10.1097/00007890-199709270-00024. Transplantation. 1997. PMID: 9326423

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

69 results

Search Page